Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-12.84	39.56	45.38
Graham Fair Price	49.77	15288.06	10207.70
PEG	-54.39	0.13	-0.29
Price/Book	-6.76	0.29	0.31
Price/Cash Flow	478.11	-113.83	19.69
Prices/Earnings	-58.06	16.57	39.52
Price/Sales	-18.27	2.95	3.61
Price/FCF	478.11	-113.83	19.69
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-4.89	0.26	0.27
Operating Margin	10.23	0.08	0.08
ROA	121.79	< 0.005	< 0.005
ROE	< 0.005	< 0.005	122.34
ROIC	< 0.005	< 0.005	58.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.20	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.16	0.26	-87.82
EPS QOQ	1.34	1.23	-8.06
FCF QOQ	0.44	-1.16	164.87
Revenue QOQ	< 0.005	0.15	7267.16
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	106.53	91.46	-14.15
Days Sales Outstanding (DSO)	81.08	85.28	5.18
Inventory Turnover	0.84	0.98	16.48
Debt/Capitalization	0.15	0.15	-0.37
Quick Ratio	1.11	1.13	1.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	48380.32	74582.07	54.16
Cash	7894.78	7751.98	-1.81
Capex	-0.50	119.57	23973.95
Free Cash Flow	768.38	-124.48	-83.80
Revenue	4193.86	4805.77	14.59
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.46	1.47	0.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.42	10.79	-13.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating